Actinium Pharmaceuticals, Inc. (ATNM)

NYSEAMERICAN: ATNM · Real-Time Price · USD

1.220

+0.030 (2.52%)

At close: Sep 18, 2026, 4:00 PM EDT

1.250

+0.030 (2.46%)

After-hours: Sep 18, 2026, 8:00 PM EDT

Actinium Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	36.47	48	72.9	76.68	108.91	77.83
Cash & Short-Term Investments	36.47	48	72.9	76.68	108.91	77.83
Cash Growth	-39.14%	-34.16%	-4.92%	-29.60%	39.93%	22.45%
Prepaid Expenses	1.27	1.38	1.6	1.59	1.64	1.48
Restricted Cash	-	-	-	-	0.4	0.39
Other Current Assets	-	-	-	-	-	0.05
Total Current Assets	37.74	49.38	74.51	78.26	110.94	79.75
Property, Plant & Equipment	2.08	2.06	2.07	2.87	2.95	0.64
Other Long-Term Assets	0.34	0.34	0.32	0.31	0.3	-
Total Assets	40.16	51.78	76.9	81.45	114.19	80.39

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	8.51	7.25	7.57	7.95	10.13	5.54
Current Portion of Leases	0.75	0.72	0.58	0.54	0.5	0.31
Current Unearned Revenue	-	-	-	-	-	1
Total Current Liabilities	9.26	7.97	8.15	8.49	10.63	6.84
Long-Term Leases	0.6	0.97	0.99	1.57	2.08	0
Long-Term Unearned Revenue	-	35	35	35	35	-
Total Liabilities	9.86	43.94	44.14	45.07	47.71	6.84

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.03	0.03	0.03	0.03	0.03	0.02
Additional Paid-In Capital	417.67	417.54	408.55	373.93	355.22	329.27
Retained Earnings	-387.33	-409.71	-375.83	-337.58	-288.77	-255.75
Comprehensive Income & Other	-0.06	-0.02	-	-	-	-
Shareholders' Equity	30.3	7.83	32.76	36.38	66.48	73.55
Total Liabilities & Equity	40.16	51.78	76.9	81.45	114.19	80.39

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	1.34	1.69	1.57	2.11	2.58	0.31
Net Cash (Debt)	35.13	46.3	71.33	74.56	106.33	77.52
Net Cash Growth	-40.09%	-35.09%	-4.34%	-29.87%	37.16%	23.39%
Net Cash Per Share	1.12	1.48	2.37	2.80	4.40	3.77
Filing Date Shares Outstanding	31.44	31.18	31.2	29.4	25.73	22.14
Total Common Shares Outstanding	31.44	31.2	31.2	27.63	25.67	22.14
Working Capital	28.48	41.41	66.36	69.77	100.31	72.91
Book Value Per Share	0.96	0.25	1.05	1.32	2.59	3.32
Tangible Book Value	30.3	7.83	32.76	36.38	66.48	73.55
Tangible Book Value Per Share	0.96	0.25	1.05	1.32	2.59	3.32
Machinery	-	1.26	1.26	1.24	1.09	0.68
Construction In Progress	-	0.1	-	-	-	-

SEC Filings: 10-K · 10-Q